Shalaks Pharmaceuticals Pvt. Ltd.

SAN FRANCISCO – Invida Group Pte. Ltd. CEO John Graham has helped build a company focused on commercializing differentiated products in Asian markets primarily through partnerships with small and

SAN FRANCISCO – Invida Group Pte. Ltd. CEO John Graham has helped build a company focused on commercializing differentiated products in Asian markets primarily through partnerships with small and

Financings In the fourth quarter of 2011, biopharma financings more than doubled to $2.7 billion from the previous quarter’s $1.4 billion, bringing total funding for 2011 to $14.1 billion. ( See Exhib

MUMBAI – After a relatively dull 2011 for deals, investment bankers and consultants in India are reconfiguring their pitches to pharma, now concentrating mostly on smaller transactions from overseas p